Newsletter | April 12, 2025

04.12.25 -- Life Science Leader Best Of March

MARCH'S BEST FEATURED EDITORIAL

Resetting The Immune System For Lasting Remission

By Iain Kilty

Sitryx CEO Iain Kilty describes the biopharmaceutical industry effort to go beyond immunosuppression in autoimmune and inflammatory conditions, using novel targets and improved modalities.

MARCH'S BEST INDUSTRY INSIGHTS

Antibody-Drug Conjugates: 'Magic Bullets' Become Reality

Cancer therapy has evolved from potent chemotherapy to targeted biological therapy, including ADCs. Learn more about ADCs’ makeup, mechanisms, and the development landscape.

Five Predictions For Clinical Research In 2025

In 2025, AI-powered adaptive protocols will redefine study design, shifting the industry from rigid, pre-planned models to flexible, real-world-optimized trials.

The Digital Pharmaceutical Journey: 2025 And Beyond

By 2025 and beyond, AI, structured data, and real-world evidence will reshape the landscape, driving personalized medicine and more efficient processes. Here are eight key trends to watch.